miRNAs and related polymorphisms in rheumatoid arthritis susceptibility

Anthoula Chatzikyriakidou1, Paraskevi V Voulgari, Ioannis Georgiou

  • 1Genetics Unit, Department of Obstetrics and Gynecology, Medical School, University of Ioannina, Ioannina, Greece.

Autoimmunity Reviews
|November 22, 2011
PubMed

Insights

MicroRNAs (miRNAs) are key epigenetic regulators in rheumatoid arthritis (RA) susceptibility. This review examines specific miRNA expression patterns and polymorphisms in RA patients, proposing targets for future genetic association studies.

Area of Science:

  • Genetics
  • Epigenetics
  • Immunology

Background:

  • Rheumatoid arthritis (RA) is a complex autoimmune disease influenced by genetic and environmental factors.
  • Epigenetic mechanisms, particularly microRNAs (miRNAs), are increasingly recognized for their role in gene expression regulation.
  • Dysregulation of specific miRNAs has been observed in RA patients, suggesting their involvement in disease pathogenesis.

Purpose of the Study:

  • To review the current understanding of microRNA involvement in rheumatoid arthritis susceptibility.
  • To identify specific microRNAs and their gene targets with altered expression patterns in RA.
  • To propose novel miRNA and gene target polymorphisms for future investigation in RA predisposition.

Main Methods:

  • Literature review of genetic association studies focusing on rheumatoid arthritis.
  • Analysis of documented microRNA expression patterns in various RA patient tissue samples.
  • In silico identification and proposal of potentially significant miRNA and gene target polymorphisms using web-based tools.

Main Results:

  • Several microRNAs, including mir-146a, miRNA-155, and miRNA-124a, exhibit differential expression in rheumatoid arthritis patients.
  • Polymorphisms in these microRNAs and their gene targets have been previously associated with RA and other autoimmune diseases.
  • Specific microRNA and gene target polymorphisms are proposed for further validation in RA genetic studies.

Conclusions:

  • MicroRNAs represent a significant epigenetic regulatory layer in rheumatoid arthritis pathogenesis.
  • Investigating the role of specific miRNA polymorphisms and their targets holds promise for understanding RA susceptibility.
  • Further genetic association studies are warranted to elucidate the precise contribution of these epigenetic factors to RA predisposition.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...